HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Minipulses of cyclophosphamide in the treatment of dermatopolymyositis with lung involvement].

Abstract
A new scheme for the treatment of dermatopolymyositis with pulmonary fibrosis not responding to corticosteroid therapy is presented. Monthly endovenous administration of a small dose of cyclophosphamide is advocated. Two patients with dermatopolymyositis not responding to prednisone were treated for two years with small doses of cyclophosphamide given monthly after which recovered from muscular and pulmonary involvement showing at present normal clinical parameters.
AuthorsV Takayasu, E Hirose-Pastor, R Fuller, M C Vilar, N Yoshinari, W Cossermelli
JournalRevista do Hospital das Clinicas (Rev Hosp Clin Fac Med Sao Paulo) 1992 Sep-Oct Vol. 47 Issue 5 Pg. 240-4 ISSN: 0041-8781 [Print] Brazil
Vernacular TitleMini-pulsos de ciclofosfamida no tratamento da dermatopolimiosite com envolvimento pulmonar.
PMID1340610 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Cyclophosphamide
Topics
  • Adult
  • Chronic Disease
  • Cyclophosphamide (administration & dosage)
  • Dermatomyositis (complications, diagnosis, drug therapy)
  • Female
  • Humans
  • Male
  • Pulmonary Fibrosis (diagnosis, drug therapy, etiology)
  • Remission Induction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: